Life Extension Skin Care Sale

DHEA Restoration Therapy


Abraham SB, Rubino D, Sinaii N, Ramsey S, Nieman LK. Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature. Obesity (Silver Spring, Md.). Jan 2013;21(1):E105-117.

Adachi M, Takayanagi R. Role of androgens and DHEA in bone metabolism, Clin Calcium 2006 Jan; 16(1):61-6.

Ahmed LA, Schirmer H, Bjornerem A, Emaus N, Jorgensen L, Stormer J, Joakimsen RM. The gender- and age-specific 10-year and lifetime absolute fracture risk in Tromso, Norway. Eur J Epidemiol. 2009;24(8):441-8.

Aldred S, Mecocci P. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients. Arch Gerontol Geriatr. 2010 Jul-Aug;51(1):e16-8.

Alhaj HA, Massey AE, McAllister-Williams RH. Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study. Psychopharmacology (Berl). 2006 Nov; 188(4):541-51.

Amato RJ, Hulin MW, Winsauer PJ. A comparison of dehydroepiandrosterone and 7-keto dehydroepiandrosterone with other drugs that modulate ethanol intake in rats responding under a multiple schedule. Behavioural pharmacology. Jun 2012;23(3):250-261.

Arlt W, Haas J, Callies F, Reincke M, Hubler D, Oettel M, . . . Allolio B. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. The Journal of clinical endocrinology and metabolism. Jun 1999;84(6):2170-2176.

Arlt W, Justl HG, Callies F, Reincke M, Hubler D, Oettel M, . . . Allolio B. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. The Journal of clinical endocrinology and metabolism. Jun 1998;83(6):1928-1934.

Arlt W. Androgen therapy in women.  Eur J Endocrinol. 2006 Jan; 154(1):1-11.

Barrett-Connor E, Khaw KT, Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. The New England journal of medicine. Dec 11 1986;315(24):1519-1524.

Basat O, Ucak S, Ozkurt H, Basak M, Seber S, Altuntas Y. Visceral adipose tissue and an indicator of insulin resistance in nonobese patients with new onset type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2006;114(2):58-62.

Baulieu EE, Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proceedings of the National Academy of Sciences of the United States of America. Apr 14 1998;95(8):4089-4091.

Belanger A, Candas B, et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J CLin Endocrinol Metab . 1994;79:1086-1090.

Berr C, Lafont S, Debuire B, Dartigues JF, Baulieu EE. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proceedings of the National Academy of Sciences of the United States of America. Nov 12 1996;93(23):13410-13415.

Bloch M, Schmidt PJ, Danaceau MA, Adams LF, Rubinow DR. Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry. 1999 Jun 15;45(12):1533-41.

Bobyleva V, Bellei M, Kneer N, Lardy H. The effects of the ergosteroid 7-oxo-dehydroepiandrosterone on mitochondrial membrane potential: possible relationship to thermogenesis. Archives of biochemistry and biophysics. May 1 1997;341(1):122-128.

Bradley M, McElhiney M, Rabkin J. DHEA and Cognition in HIV-Positive Patients with Non-Major Depression. Psychosomatics 2012 53 (3):244–249

Brazão V, Santello FH, Caetano LC, Del Vecchio Filipin M, Paula Alonso Toldo M, do Prado JC, Jr. Immunomodulatory effects of zinc and DHEA on the Th-1 immune response in rats infected with Trypanosoma cruzi. Immunobiology. 2010 May;215(5):427-34.

Brignardello E, Runzo C, Aragno M, et al. Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients. Diabetes Care. 2007 Nov; 30(11):2922-7.

Brooke AM, Kalingag LA, Miraki-Moud F, et al. Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement. J Clin Endocrinol Metab. 2006 Oct; 91(10):3773-9.

Buford TW, Willoughby DS. Impact of DHEA(S) and cortisol on immune function in aging: a brief review. Appl Physiol Nutr Metab. 2008 Jun;33(3):429-33.

Buoso E, Lanni C, Molteni E, Rousset F, Corsini E, Racchi M. Opposing effects of cortisol and dehydroepiandrosterone on the expression of the receptor for Activated C Kinase 1: implications in immunosenescence. Experimental gerontology. Nov 2011;46(11):877-883.

Butcher SK, Killampalli V, Lascelles D, Wang K, Alpar EK, Lord JM. Raised cortisol:DHEAS ratios in the elderly after injury: potential impact upon neutrophil function and immunity. Aging cell. Dec 2005;4(6):319-324.

Caetano LC, Santello FH, Del Vecchio Filipin M, et al. Trypanosoma cruzi: dehydroepiandrosterone (DHEA) and immune response during the chronic phase of the experimental Chagas’ disease. Vet Parasitol. 2009 Jul 7;163(1-2):27-32.

Calvo E, Luu-The V, Morissette J, et al. Pangenomic changes induced by DHEA in the skin of postmenopausal women. J Steroid Biochem Mol Biol. 2008 Dec; 112(4-5):186-93.

Cameron DR , Braunstein GD. The use of dehydroepiandrosterone therapy in clinical practice. Treat Endocrinol . 2005;4(2):95-114.

Cappola AR, O'Meara ES, Guo W, Bartz TM, Fried LP, Newman AB. Trajectories of dehydroepiandrosterone sulfate predict mortality in older adults: the cardiovascular health study. The journals of gerontology. Series A, Biological sciences and medical sciences. Dec 2009;64(12):1268-1274.

Cawthon PM. Gender Differences in Osteoporosis and Fractures. Clin Orthop Relat Res. 2011 Jul;469(7):1900-5

Chan CC, Liou CJ, Xu PY, Shen JJ, Kuo ML, Len WB, . . . Huang WC. Effect of dehydroepiandrosterone on atopic dermatitis-like skin lesions induced by 1-chloro-2,4-dinitrobenzene in mouse. Journal of dermatological science. Jul 9 2013.

Chang DM, Lan JL. et al. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum . 2002 Nov;46(11):2924-7.

Charalampopoulos I, Remboutsika E, Margioris AN, Gravanis A.   Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol Metab. 2008 Oct; 19(8):300-7.

Chlebowski RT, Anderson GL, Gass M, et al. WHI Investigators. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA. 2010 Oct 20;304(15):1684-92.

Choi IS, Cui Y, Koh YA, Lee HC, Cho YB, Won YH, Effects of dehydroepiandrosterone on Th2 cytokine production in peripheral blood mononuclear cells from asthmatics. Korean J Intern Med. 2008 Dec; 23(4):176-81.

Corina M, Vulpoi C, Branisteanu D. Relationship between bone mineral density, weight, and estrogen levels in pre- and postmenopausal women. Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):946-50.

Crosbie D, Black C, McIntyre L, Royle PL, Thomas S. Dehydroepiandrosterone for systemic lupus erythematosus. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005114.

Davidson M, Marwah A, Sawchuk RJ, Maki K, Marwah P, Weeks C, Lardy H. Safety and pharmacokinetic study with escalating doses of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy male volunteers. Clin Invest Med. 2000 Oct;23(5):300-10.

Davis W. Don’t Fall Victim to Frailty. Life Extension Magazine March 2010.

Dhatariya K, Bigelow ML, Nair KS. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes. 2005 Mar;54(3):765-9.

Dong Y, Zheng P. Dehydroepiandrosterone sulphate: action and mechanism in the brain. J Neuroendocrinol. 2012 Jan;24(1):215-24.

Dong Y, Zheng P. Dehydroepiandrosterone sulphate: action and mechanism in the brain. Journal of neuroendocrinology. Jan 2012;24(1):215-224.

Drbalová K, Matucha P, Matejková-Behanová M, Bílek R, Kríz L, Kazihnitková H, Hampl R. Immunoprotective steroids and SHBG in non-treated hypothyroidism and their relationship to autoimmune thyroid disorders. Physiol Res. 2008;57 Suppl 1:S119-25.

Dumas de la Roque E, Savineau JP, Bonnet S. Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension. Pharmacology & therapeutics. May 2010;126(2):186-199.

Duskova M, Simunkova K, Hill M, Starka L. 7-hydroxylated derivatives of dehydroepiandrosterone as possibly related to menstrual mood change in healthy women. Endocr Regul. 2011 Jul; 45(3):131-7

El-Alfy M, Deloche C, Azzi L, Bernard BA, Bernerd F, Coutet J, Chaussade V, Martel C, Leclaire J, Labrie F. Skin responses to topical dehydroepiandrosterone: implications in antiageing treatment? Br J Dermatol. 2010 Nov;163(5):968-76.

Enomoto M, Adachi H, Fukami A, Furuki K, Satoh A, Otsuka M, . . . Imaizumi T. Serum dehydroepiandrosterone sulfate levels predict longevity in men: 27-year follow-up study in a community-based cohort (Tanushimaru study). Journal of the American Geriatrics Society. Jun 2008;56(6):994-998.

Fingerova H, Matlochova J. [Reduced serum dehydroepiandrosterone levels in postmenopausal osteoporosis]. Ceska gynekologie / Ceska lekarska spolecnost J. Ev. Purkyne. Apr 1998;63(2):110-113.

Fitzpatrick JL, Ripp SL, Smith NB, Pierce WM, Jr., Prough RA. Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractions. Archives of biochemistry and biophysics. May 15 2001;389(2):278-287.

Ganong WF, 'Review of Medical Physiology', 22nd Ed, McGraw Hill, 2005, page 362

Genazzani AR, Stomati M, Valentino V, Pluchino N, Pot E, Casarosa E, Merlini S, Giannini A, Luisi M. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality. Climacteric. 2011 Dec;14(6):661-8.

Glei DA, Goldman N. Dehydroepiandrosterone sulfate (DHEAS) and risk for mortality among older Taiwanese. Annals of epidemiology. Jul 2006;16(7):510-515.

Gómez-Santos C, Hernández-Morante JJ, Tébar FJ, Granero E, Garaulet M. Differential effect of oral dehydroepiandrosterone-sulphate on metabolic syndrome features in pre- and postmenopausal obese women. Clin Endocrinol (Oxf). 2012 Oct;77(4):548-54.

Gómez-Santos C, Larque E, Granero E, Hernandez-Morante JJ, Garaulet M. Dehydroepiandrosterone-sulphate replacement improves the human plasma fatty acid profile in plasma of obese women. Steroids. Dec 11 2011;76(13):1425-1432.

Hakkak R, Shaaf S, Jo CH, MacLeod S, Korourian S. Dehydroepiandrosterone intake protects against 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in the obese Zucker rat model. Oncology reports. Aug 2010;24(2):357-362.

Hampl R, Stárka L, Janský L. Steroids and thermogenesis. Physiol Res. 2006; 55(2):123-31.

Hampl R, Sulcová J, Bílek R, Hill M. How short-term transdermal treatment of men with 7-oxo-dehydroepiandrosterone influence thyroid function. Physiol Res. 2006; 55(1):49-54.

Hauffa BP, Kaplan SL, et al. Dissociation between plasma adrenal androgens and cortisol in Cushing's disease and ectopic ACTH-producing tumour: relation to adrenarche. Lancet . 1984 Jun 23;1(8391):1373-6.

Hazeldine J, Arlt W, Lord JM. Dehydroepiandrosterone as a regulator of immune cell function. J Steroid Biochem Mol Biol. 2010 May 31;120(2-3):127-36.

Hennebert O, Chalbot S, Alran S, Morfin R. Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J Steroid Biochem Mol Biol. 2007 May;104(3-5):326-33.

Herbert, J. Neurosteroids, brain damage, and mental illness. Exp Gerontol. 1998 Nov-Dec;33(7-8):713-27.

Hinson JP, Raven PW. DHEA deficiency syndrome: a new term for old age? The Journal of endocrinology. Oct 1999;163(1):1-5.

Holtorf K. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? Postgrad Med. 2009;121(1): 73-85.

Holtorf K. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? Postgraduate medicine. Jan 2009;121(1):73-85.

Hsu HJ, Yen CH, Chen CK, Hsu KH, Hsiao CC, Lee CC, . . . Wu MS. Low plasma DHEA-S increases mortality risk among male hemodialysis patients. Experimental gerontology. Dec 2012;47(12):950-957.

Huerta-García E, Ventura-Gallegos JL, Victoriano ME, Montiél-Dávalos A, Tinoco-Jaramillo G, López-Marure R. Dehydroepiandrosterone inhibits the activation and dysfunction of endothelial cells induced by high glucose concentration. Steroids. 2012 Feb;77(3):233-40.

Ihler G, Chami-Stemmann H. 7-oxo-DHEA and Raynaud's phenomenon. Medical hypotheses. Mar 2003;60(3):391-397.

Ii M, Hoshiga M, Negoro N, et al. Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injury. Atherosclerosis. 2009 Sep;206(1):77-85.

James K, Premchand N, et al. IL-6, DHEA and the ageing process. Mech Ageing Dev . 1997 Feb;93(1-3):15-24.

Jansson JH, Nilsson TK, Johnson O. von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction. Heart (British Cardiac Society). Oct 1998;80(4):334-337.

Kakiya R, Shoji T, Hayashi T, Tatsumi-Shimomura N, Tsujimoto Y, Tabata T, . . . Inaba M. Decreased serum adrenal androgen dehydroepiandrosterone sulfate and mortality in hemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. Oct 2012;27(10):3915-3922.

Kawate H, Takayanagi R. [Secondary osteoporosis UPDATE. Treatment of male osteoporosis. Testosterone replacement therapy etc]. Clin Calcium. 2010 May;20(5):744-51.

Kenny AM, Boxer RS, Kleppinger A, Brindisi J, Feinn R, Burleson JA. Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J Am Geriatr Soc. 2010 Sep;58(9):1707-14.

Khorram O, Vu L, et al. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A Biol Sci Med Sci . 1997 Jan;52(1):M1-M7.

Krysiak R, Frysz-Naglak D, Okopien B. [Current views on the role of dehydroepiandrosterone in physiology, pathology and therapy]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. Jan 2008;24(139):66-71.

Krysiak R, Frysz-Naglak D, Okopień B. Current views on the role of dehydroepiandrosterone in physiology, pathology and therapy. Pol Merkur Lekarski. 2008 Jan;24(139):66-71.

Kurita H, Maeshima H, Kida S, Matsuzaka H, Shimano T, Nakano Y, Baba H, Suzuki T, Arai H. Serum dehydroepiandrosterone (DHEA) and DHEA-Sulfate (S) levels in medicated patients with major depressive disorder compared with controls. J Affect Disord. 2012 Oct 25. pii: S0165-0327(12)00623-4.

LabCorp. Dehydroepiandrosterone (DHEA) Sulfate. Available at:!ut/p/c1/ hY1LDoIwFADP4gFMHwUqbDXlI1CsRflsCAFDMPwxGDi9XEDNLCeTQQnaaLO5KrNX1bVZjSKUkJ RrhHHMMGgeNgDL5AjqiUpgks3H3z3An5pZXfNAMUoO6Y0qQrJ1GXxTYLCF7CsMM0I0QAGKQEn FE3rPnVpv1f2LS1Xm0tHPnRGCAaZ10R3ghXO-FnU98LAM74FX20ERz1K-yI7BrXQQR9he8c9X30Rvac93H5v96_Y!/ dl2/d1/L0lJS2FZQSEhL3dMRUJGcUFFQWpNQy9ZSTV5bHchIS83X1VFNFMxSTkzME9HUzIwSVMzTzROMk42 NjgwL3ZpZXdUZXN0/?testId=408381 Accessed 8/29/2013.

Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause. 2009 Sep-Oct; 16(5):923-31

Labrie F. DHEA, important source of sex steroids in men and even more in women. Prog Brain Res. 2010;182:97-148.

Lazaridis I, Charalampopoulos I, Alexaki VI, Avlonitis N, Pediaditakis I, Efstathopoulos P, . . . Gravanis A. Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis. PLoS biology. Apr 2011;9(4):e1001051.

Leowattana W. DHEA(S): the fountain of youth. J Med Assoc Thai . 2001 Oct;84(Suppl 2):S605-S612.

Li Y, Xia Z, Wang M. Dehydroepiandrosterone inhibits CD40/CD40L expression on human umbilical vein endothelial cells induced by interferon gamma. Int Immunopharmacol. 2009 Feb; 9(2):168-72

Liu D, Dillon JS. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). The Journal of biological chemistry. Jun 14 2002;277(24):21379-21388.

Liu D, Dillon JS. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids. Apr 2004;69(4):279-289.

Lopez-Marure R, Contreras PG, Dillon JS. Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells. European journal of pharmacology. Jun 25 2011;660(2-3):268-274.

Luppi C, Fioravanti M, Bertolini B, Inguscio M, Grugnetti A, Guerriero F, Rovelli C, Cantoni F, Guagnano P, Marazzi E, Rolfo E, Ghianda D, Levante D, Guerrini C, Bonacasa R, Solerte SB. Growth factors decrease in subjects with mild to moderate Alzheimer's disease (AD): potential correction with dehydroepiandrosterone-sulphate (DHEAS). Arch Gerontol Geriatr. 2009;49 Suppl 1:173-84.

Lutsenko MT, Andrievskaia IA, Dovzhikova IV.  [DHEA-S synthesis during pregnancy with cytomegalovirus infection]. Arkh Patol. 2012 Jan-Feb;74(1):46-7.

Manabe A, et al. Nitric oxide synthesis is increased after dehydroepiandrosterone sulphate administration in term human pregnancy. Human Reproduction 1999 14(8): 2116-2119.

Marder W, Somers EC, Kaplan MJ, Anderson MR, Lewis EE, McCune WJ. Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study. Lupus. 2010 Sep;19(10):1229-36.

Marin P, Darin N, Amemiya T, Andersson B, Jern S, Bjorntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism: clinical and experimental. Aug 1992;41(8):882-886.

Martina V, Benso A, Gigliardi VR, Masha A, Origlia C, Granata R, Ghigo E. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects. Clin Endocrinol (Oxf). 2006 Mar; 64(3):260-4.

Mayo Clinic. DHEA. Available at: 2012.

Mazat L, Lafont S, Berr C, Debuire B, Tessier JF, Dartigues JF, Baulieu EE. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proceedings of the National Academy of Sciences of the United States of America. Jul 3 2001;98(14):8145-8150.

Miller KK, Cai J, Ripp SL, Pierce WM, Jr., Rushmore TH, Prough RA. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450. Drug metabolism and disposition: the biological fate of chemicals. Mar 2004;32(3):305-313.

Mitchell LE, Sprecher DL, Borecki IB, Rice T, Laskarzewski PM, Rao DC. Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation. 1994 Jan; 89(1):89-93.

Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 1994 Jun;78(6):1360-7.

Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. The Journal of clinical endocrinology and metabolism. Jun 1994;78(6):1360-1367.

Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila D, Jr., Khera M. Testosterone therapy in men with untreated prostate cancer. The Journal of urology. Apr 2011;185(4):1256-1260.

Morgentaler A. Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancer. Cancer. Sep 1 2011;117(17):3885-3888.

Moyer AE, Rodin J, Grilo CM, Cummings N, Larson LM, Rebuffe-Scrive M. Stress-induced cortisol response and fat distribution in women. Obesity research. May 1994;2(3):255-262.

Mueck AO, Seeger H, Buhling KJ. Use of dydrogesterone in hormone replacement therapy. Maturitas. 2009 Dec;65 Suppl 1:S51-60.

Muller C, Hennebert O, Morfin R. The native anti-glucocorticoid paradigm. J Steroid Biochem Mol Biol. 2006 Jul; 100(1-3):95-105.

Nouveau S, Bastien P, Baldo F, de Lacharriere O. Effects of topical DHEA on aging skin: a pilot study. Maturitas. 2008 Feb 20;59(2):174-81.

Nuti R, Merlotti D, Francucci CM, Gennari L. Bone fragility in men: where are we? J Endocrinol Invest. 2010;33(7 Suppl):33-8.

Ohlsson C, Labrie F, Barrett-Connor E, Karlsson MK, Ljunggren O, Vandenput L, . . . Tivesten A. Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men. The Journal of clinical endocrinology and metabolism. Sep 2010;95(9):4406-4414.

Okuno S, Inaba M, Kitatani K, Ishimura E, Yamakawa T, Nishizawa Y. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients. Osteoporos Int. 2005 May;16(5):501-9. Epub 2004 Aug 11.

Orentreich N, Brind JL, et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab . 1984 Sep;59(3):551-5.

Panjari M, Davis SR. DHEA therapy for women: effect on sexual function and wellbeing. Human reproduction update. May-Jun 2007;13(3):239-248.

Phillips AC, Carroll D, Gale CR, Lord JM, Arlt W, Batty GD. Cortisol, DHEA sulphate, their ratio, and all-cause and cause-specific mortality in the Vietnam Experience Study. European journal of endocrinology / European Federation of Endocrine Societies. Aug 2010;163(2):285-292.

Ponholzer A, Madersbacher S, Rauchenwald M, Jungwirth S, Fischer P, Tragl KH. Vascular risk factors and their association to serum androgen levels in a population-based cohort of 75-year-old men over 5 years: results of the VITA study. World J Urol. 2009 Apr;28(2):209-14.

Ponikowska B, Jankowska EA, Maj J, et al. Gonadal and adrenal androgen deficiencies as independent predictors of increased cardiovascular mortality in men with type II diabetes mellitus and stable coronary artery disease. Int J Cardiol.  2010 Sep 3;143(3):343-8.

Puizina-Ivić N, Mirić L, Carija A, Karlica D, Marasović D. Modern approach to topical treatment of aging skin. Coll Antropol. 2010 Sep;34(3):1145-53.

Rabkin JG, McElhiney MC, Rabkin R, McGrath PJ, Ferrando SJ. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS.  Am J Psychiatry. 2006 Jan; 163(1):59-66.

Ramos-Casals M, García-Carrasco M, Brito MP, López-Soto A, Font J. Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly. Lupus. 2003;12(5):341-55.

Reiter WJ, Pycha A, Schatzl G, Pokorny A, Gruber DM, Huber JC, Marberger M. Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study. Urology. 1999 Mar;53(3):590-4; discussion 594-5.

Rhoden EL, Gobbi D, Rhoden CR, et al. Effects of chronic administration of dehydroepiandrosterone on serum testosterone levels and prostatic tissue in rats. J Urol. 2003 Nov;170(5):2101-3.

Rhoden EL, Gobbi D, Rhoden CR, Menti E, Roehe AN, Hartmann A, Morgentaler A. Effects of chronic administration of dehydroepiandrosterone on serum testosterone levels and prostatic tissue in rats. The Journal of urology. Nov 2003;170(5):2101-2103.

Ritsner, MS. The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia. Neuroscience. 2011 Sep 15; 191:91-100.

Roxas M, Jurenka J. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev. 2007 Mar;12(1):25-48.

Samaras N, Samaras D, Frangos Lordos E, Forster A, Philippe J. A review of age related dehydroepiandrosterone (DHEA) decline and its association with well-known geriatric syndromes. Is treatment beneficial? Rejuvenation research. May 7 2013.

Sanders JL, Cappola AR, Arnold AM, Boudreau RM, Chaves PH, Robbins J, . . . Newman AB. Concurrent change in dehydroepiandrosterone sulfate and functional performance in the oldest old: results from the Cardiovascular Health Study All Stars study. The journals of gerontology. Series A, Biological sciences and medical sciences. Sep 2010;65(9):976-981.

Santos CD, Toldo MP, Santello FH, Filipin Mdel V, Brazão V, do Prado Júnior JC. Dehydroepiandrosterone increases resistance to experimental infection by Trypanosoma cruzi. Vet Parasitol. 2008 May 31;153(3-4):238-43.

Savineau JP, Marthan R, Dumas de la Roque E. Role of DHEA in cardiovascular diseases. Biochemical pharmacology. Mar 15 2013;85(6):718-726.

Schulze J, Johansson M, Thorngren JO, Garle M, Rane A, Ekstrom L. SULT2A1 Gene Copy Number Variation is Associated with Urinary Excretion Rate of Steroid Sulfates. Frontiers in endocrinology. 2013;4:88.

Shufelt C, Bretsky P, Almeida CM, Johnson BD, Shaw LJ, Azziz R, Braunstein GD, Pepine CJ, Bittner V, Vido DA, Stanczyk FZ, Bairey Merz CN. DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).  J Clin Endocrinol Metab. 2010 Nov;95(11):4985-92.

Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology. Aug 2003;144(8):3449-3455.

Simunkova K, Hampl R, Hill M, Kriz L, Hrda P, Janickova-Zdarska D, Zamrazil V, Vrbikova J, Vondra K. Adrenocortical function in young adults with diabetes mellitus type 1. J Steroid Biochem Mol Biol. 2010 Oct;122(1-3):35-41.

Sorwell KG, Urbanski HF. Dehydroepiandrosterone and age-related cognitive decline. Age (Dordr). 2010 Mar;32(1):61-7.

Srinivasan M, Irving BA, Dhatariya K, et al. Effect of dehydroepiandrosterone replacement on lipoprotein profile in hypoadrenal women. J Clin Endocrinol Metab. 2009 Mar;94(3):761-4.

Stangl B, Hirshman E, Verbalis J. Administration of dehydroepiandrosterone (DHEA) enhances visual-spatial performance in postmenopausal women. Behav Neurosci. 2011 Oct;125(5):742-52.

Steinberger J, Daniels S. Obesity, Insulin Resistance, Diabetes, and Cardiovascular Risk in Children. Circulation. 2003;107:1448-53.

Straub RH, Konecna L, et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab . 1998 Jun;83(6):2012-7.

Straub RH, Lehle K, et al. Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor. Eur J Endocrinol . 2002a Mar;146(3):365-74.

Straub RH, Scholmerich J, Zietz B. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases--substitutes of adrenal and sex hormones. Zeitschrift fur Rheumatologie. 2000;59 Suppl 2:Ii/108-118.

Strous RD, Maayan R, Kotler M, Weizman A. Hormonal profile effects following dehydroepiandrosterone (DHEA) administration to schizophrenic patients. Clin Neuropharmacol. 2005 Nov-Dec;28(6):265-9.

Talaei A, Amini M, Siavash M, Zare M. The effect of dehydroepiandrosterone on insulin resistance in patients with impaired glucose tolerance. Hormones (Athens). 2010 Oct-Dec;9(4):326-31.

Traish AM, Kang HP, Saad F, Guay AT. Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology. The journal of sexual medicine. Nov 2011;8(11):2960-2982; quiz 2983.

Trevano J. State of California Decrees Strong Warning Labels on DHEA and Pregnenolone. Life Extension. July. 2011.

Trivedi DP, Khaw KT. Dehydroepiandrosterone sulfate and mortality in elderly men and women. The Journal of clinical endocrinology and metabolism. Sep 2001;86(9):4171-4177.

Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr Rev. 2006 Oct;27(6):575-605.

UMMC. University of Maryland Medical Center (UMMC). Dehydroepiandrosterone. Available at: 2013.

Valenti G, Ferrucci L, Lauretani F, et al. Dehydroepiandrosterone and cognitive function in the elderly: The InCHIANTI Study. J Endocrinol Invest. 2009 Oct; 32(9):766-72.

van Broekhoven F, Verkes RJ. Neurosteroids in depression: a review. Psychopharmacology (Berl). 2003 Jan;165(2):97-110. Epub 2002 Nov 6.

van Vollenhoven RF, Morabito LM, et al. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. J Rheumatol . 1998 Feb;25(2):285-9.

von Mühlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteoporos Int. 2008 May;19(5):699-707.

Wang YD, Tao MF, Cheng WW, Liu XH, Wan XP, Cui K. Dehydroepiandrosterone indirectly inhibits human osteoclastic resorption via activating osteoblastic viability by the MAPK pathway.  Chin Med J (Engl). 2012 Apr; 125(7):1230-5.

Wang YD, Wang L, Li DJ, Wang WJ. Dehydroepiandrosterone inhibited the bone resorption through the upregulation of OPG/RANKL. Cell Mol Immunol. 2006 Feb; 3(1):41-5.

Weiss EP, et al. Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans. Aging (Albany NY). 2011 May; 3(5): 533–542.

Weiss EP, et al. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr. 2009 May; 89(5): 1459–1467.

Whetzel CA, Klein LC. Measuring DHEA-S in saliva: time of day differences and positive correlations between two different types of collection methods. BMC Research Notes 2010, 3:204

Wong SY, Leung JC, Kwok T, Ohlsson C, Vandenput L, Leung PC, Woo J. Low DHEAS levels are associated with depressive symptoms in elderly Chinese men: results from a large study. Asian J Androl. 2011 Nov;13(6):898-902.

Worrel ME, Gurkovskaya OV, Leonard ST, Lewis PB, Winsauer PJ. Effects of 7-keto dehydroepiandrosterone on voluntary ethanol intake in male rats. Alcohol (Fayetteville, N.Y.). Jun 2011;45(4):349-354.

Yaffe K, Ettinger B, Pressman A, Seeley D, Whooley M, Schaefer C, Cummings S. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol Psychiatry. 1998 May 1;43(9):694-700.

Yamada S, Akishita M, Fukai S, Ogawa S, Yamaguchi K, Matsuyama J, Kozaki K, Toba K, Ouchi Y. Effects of dehydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment. Geriatr Gerontol Int. 2010 Oct;10(4):280-7.

Yasui T, Matsui S, Tani A, Kunimi K, Yamamoto S, Irahara M. Androgen in postmenopausal women. J Med Invest. 2012;59(1-2):12-27.

Załuska M, Janota B.  [Dehydroepiandrosteron (DHEA) in the mechanisms of stress and depression]. Psychiatr Pol. 2009 May-Jun;43(3):263-74.

Zenk JL, Frestedt JL, Kuskowski MA. HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults. J Nutr Biochem. 2007 Sep; 18(9):629-34.